Health Insurers Will Now Cover Wegovy, the Wildly Popular $1,349 Weight-Loss Drug People on Medicare with heart-related conditions may now be covered
Semaglutide, available under names like Wegovy, Ozempic, and Rybelsus, is a prescribed injectable medication for adults and children aged 12 and above dealing with obesity or excess weight along with weight-related medical issues, aiding in weight loss and maintenance
Different injection sites were not of importance for exposure, suggesting that patients can use them interchangeably if desired
Findings concluded that there was an average of 8.3 percent reduction in body weight among those taking 1mg of semaglutide per day compared to the placebo group
Try drinking water throughout the day, via small sips instead of large gulps